Mutational analysis of MLH1 and MSH2 in 25 prospectively-acquired RER+ endometrial cancers

Mutations in the DNA mismatch repair (MMR) genes MLH1 and MSH2 have been linked to several human cancers which display the replication error (RER) phenotype. Germline mutations in these two genes have been implicated in about 90% of families with hereditary nonpolyposis colorectal cancer (HNPCC). A...

Full description

Saved in:
Bibliographic Details
Published in:Genes chromosomes & cancer Vol. 18; no. 3; pp. 219 - 227
Main Authors: Kowalski, Lynn D., Mutch, David G., Herzog, Thomas J., Rader, Janet S., Goodfellow, Paul J.
Format: Journal Article
Language:English
Published: New York Wiley Subscription Services, Inc., A Wiley Company 01-03-1997
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mutations in the DNA mismatch repair (MMR) genes MLH1 and MSH2 have been linked to several human cancers which display the replication error (RER) phenotype. Germline mutations in these two genes have been implicated in about 90% of families with hereditary nonpolyposis colorectal cancer (HNPCC). A significant proportion of endometrial cancers, the second most common malignancy of the HNPCC syndrome, also exhibit RER. We screened 125 primary endometrial adenocarcinomas with seven microsatellite markers and identified 25 specimens with RER (20%). We used single‐strand conformation variant analysis to search for mutations in MLH1 and MSH2. Direct sequencing of variants revealed only one germline mutation in MLH1 and a single somatic mutation in MSH2. However, six previously unreported sequence polymorphisms in MLH1 were identified. Four of these polymorphisms show clear population‐based differences in allele frequency. In addition, a highly informative marker for MLH1 was characterized. The low frequency of mutations in MLH1 and MSH2 in this large series of cancers suggests that other MMR genes are responsible for the RER phenotype in endometrial cancers. Genes Chromosom. Cancer 18:219–227, 1997. © 1997 Wiley‐Liss, Inc.
Bibliography:ark:/67375/WNG-81WJFP7F-F
ArticleID:GCC8
istex:28F8FF4F00167AFE50E3F897984FC1FCA8938C1E
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1045-2257
1098-2264
DOI:10.1002/(SICI)1098-2264(199703)18:3<219::AID-GCC8>3.0.CO;2-4